According to a report, scientists in the UK are developing a single vaccine to fight COVID-19 and common cold. The vaccine is expected to fight against various coronavirus variants which have led to virus waves across the world leading to shutdowns and increased deaths.

UK scientists eye single jab to tackle all coronavirus variants

Pfizer CEO has said that an oral drug to treat novel coronavirus could be ready by the end of the year. Pfizer-BioNTech's coronavirus vaccine has been used in various European countries and the United States and has a very high efficacy as compared to its competitors.

Pfizer CEO says oral drug to treat coronavirus could be ready by end of 2021

Brazil on Tuesday approved the Pfizer-BioNTech coronavirus vaccine for widespread use even though it is not yet available in the country. Antonio Barra Torres, the director of Brazil's health regulatory agency Anvisa, said "It gives me great pleasure to announce that after a 17-day review, (regulators) have granted the first approval in the Americas for widespread use of a vaccine against Covid-19.

Brazil approves Pfizer-BioNTech coronavirus vaccine despite unavailability in country

pfizer-coronavirus-vaccine

Pfizer Coronavirus Vaccine, News on Pfizer Coronavirus Vaccine, stories on Pfizer Coronavirus Vaccine, articles on Pfizer Coronavirus Vaccine, Pfizer Coronavirus Vaccine stories at Wion, Pfizer Coronavirus Vaccine news, Pfizer Coronavirus Vaccine latest news

pfizer coronavirus-vaccine

UK scientists eye single jab to tackle all coronavirus variants

Pfizer CEO says oral drug to treat coronavirus could be ready by end of 2021

Brazil approves Pfizer-BioNTech coronavirus vaccine despite unavailability in country